Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Shanghai Green Valley’s Class 1 New Drug for Alzheimer’s Disease Conditionally Approved for Marketing and Already Having the Registration Approval!

PharmaSources/CaicaiNovember 14, 2019

Tag: New Drug , Alzheimer , NMPA , sodium oligomannurarate

PharmaSources Customer Service